ANAPTYSBIO, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+151.1% +$65M
$108M
R&D↓-25.6% -$11M
$31M
D&A↓-9.7% -$14K
$131K
Operating Income
$13M
EBITDA↑+9088.3% +$13M
$13M
Interest Expense
—
Other Income/Expense↓-94.1% -$9M
$-20M
Pretax Income↑+146.0% +$48M
$15M
Tax Provision
$81K
Net Income↑+146.0% +$48M
$15M
Operating Margin
12.2%
Net Margin↑+129.2pts
19.8%
Effective Tax Rate↑+0.0pts
0.0%
ETR (Continuing Operations)
-1.3%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
3.4%
Operating Lease Cost↑+0.0% +$0
$619K
Revenue YoY Variation↓-227.7pts
151.1%
Income YoY Variation↑+212.8pts
252.5%
Revenue QoQ Variation↓-1.8pts
41.8%
Income QoQ Variation
-62.0%